TherapeuticsMD IncTXMD
Price$2.03

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value Insufficient data for a value estimatebased on filings through 30 Jun 2026
Market Price $2.03Price as of 30 Sep 2026
Data confidenceNot applicable

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Discount rate (cost of equity) 8.4%
Volatility vs market (adjusted beta)0.76

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetTherapeuticsMD IncTXMDHealth Care
Valuation
P/E—
P/S7.8×
P/B0.9×
EV / Revenue4.9×
EV / EBITDA—
Profitability
Gross margin100.0%
Operating margin-9,990.0%
Net margin-6.6%
FCF margin76.5%
Returns
ROE-0.8%
ROA-0.6%
ROIC—
Growth
Revenue growth (YoY)85.7%
5-yr fwd EPS growth—
Financial strength
Debt / Equity0.00×
Current ratio3.22×
Altman Z-Score-34.0
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.